Skip to main content
Premium Trial:

Request an Annual Quote

MGH President to Leave

Peter Slavin, the president of Massachusetts General Hospital, is stepping down from that post after 18 years, the Boston Globe reports.

His departure, comes as Mass General Brigham — previously known as Partners HealthCare — undergoes restructuring, it adds. According to the Globe, this move toward an integrated healthcare system entails a transferring of power to corporate offices and away from hospitals and doctors. This, it says, in part aims to reduce internal competition between the system's hospitals. But it also means that hospital presidents no longer have the ability to launch their own large-scale projects, it says. 

The Globe notes that while the changes have led some physicians to leave, Slavin has not publicly criticized the plan.

"There is never a good time to leave," Slavin tells the Globe, noting that he will remain until a successor is chosen. "This is probably as good a time as ever. It's a good time to have a new captain of the ship."

The paper notes that Elizabeth Nabel left last month as president of Brigham and Women's Hospital.

The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Researchers Find Gene Affecting Alkaline Sensitivity in Plants

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.